欢迎访问ProbeChem中文网站,英文网站请访问www.probechem.com

首页-小分子抑制剂&激动剂-Cell Cycle/DNA Damage-Checkpoint Kinase (Chk)-Prexasertib dihydrochloride
Prexasertib dihydrochloride

Chemical Structure : Prexasertib dihydrochloride

CAS No.: 1234015-54-3

Prexasertib dihydrochloride (LY-2606368 dihydrochloride;LY 2606368 dihydrochloride;LY 2606368 dihydrochloride)

货号: PC-45428Not For Human Use, Lab Use Only.

Prexasertib (LY-2606368) dihydrochloride is a potent, selective, ATP-competitive inhibitor of CHK1 with Ki of 0.9 nM.

规格 价格 库存 数量
5 mg ¥1280 In stock
10 mg ¥1880 In stock
25 mg ¥3280 In stock
50 mg ¥5280 In stock
100 mg Get quote

大包装,大折扣!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

纯度 & COA & 质检文件 纯度: >98% (HPLC) Select Batch:

生物&药学活性

Prexasertib (LY-2606368) dihydrochloride is a potent, selective, ATP-competitive inhibitor of CHK1 with Ki of 0.9 nM.
Prexasertib (LY-2606368) potently abrogates the G2-M checkpoint activated by doxorubicin in p53-deficient HeLa cells with EC50 of 9 nM.
Prexasertib (LY-2606368) causes replication catastrophe in vitro and in vivo.
Prexasertib (LY-2606368) shows significant tumor growth inhibition in xenograft tumor models.

物理化学性质&存储条件

分子量 438.311
分子式 C18H21Cl2N7O2
外观性状 Solid
CAS No.
储存条件
固体粉末
-20 °C 12 个月; 4°C 6 个月
配置液
-80 °C 6 个月; -20°C 6 个月
Shipping
Solubility

DMSO: ≥ 32 mg/mL

Chemical Name/SMILES

2-Pyrazinecarbonitrile, 5-[[5-[2-(3-aminopropoxy)-6-methoxyphenyl]-1H-pyrazol-3-yl]amino]-, hydrochloride (1:2)

参考文献

1. King C, et al. Mol Cancer Ther. 2015 Sep;14(9):2004-13.

2. Lowery CD, et al. Clin Cancer Res. 2017 Aug 1;23(15):4354-4363.

3. Sen T, et al. Cancer Res. 2017 Jul 15;77(14):3870-3884.

备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

联系我们 sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

询单

  • *产品名称:
  • *姓名:
  • *邮箱:
  • *公司名称:
  • *询单数量:
  • *国籍:
  • 询单信息: